XORTX Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -29 | -28 | -25 | -25 |
EBITDA | -613 | -701 | -670 | 144 |
EBIT | -642 | -729 | -696 | 119 |
Net Income | -642 | -729 | -696 | 119 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -620 | -815 | -647 | -865 |
Cash | 1,661 | 1,063 | 1,895 | 2,472 |
Basic Shares | 4,856 | 3,788 | 3,737 | 3,063 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -142 | -55 | -14 | |
EBITDA | -3,706 | -2,055 | -6,941 | -1,287 |
EBIT | -3,762 | -2,197 | -6,997 | -1,301 |
Net Income | -4,763 | -2,197 | -6,997 | -1,306 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,717 | -6,629 | -8,862 | -4,786 |
Cash | 2,473 | 3,447 | 10,407 | 18,803 |
Basic Shares | 2,878 | 1,981 | 1,479 | 1,090 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.13 |
2025-06-30 | -$0.19 |
2025-03-31 | $0.04 |
2024-12-31 | -$0.81 |
